<?xml version="1.0" encoding="UTF-8"?>
<ref id="B15-cancers-10-00197">
 <label>15.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jones</surname>
    <given-names>R.J.</given-names>
   </name>
   <name>
    <surname>Seaman</surname>
    <given-names>W.T.</given-names>
   </name>
   <name>
    <surname>Feng</surname>
    <given-names>W.H.</given-names>
   </name>
   <name>
    <surname>Barlow</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Dickerson</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Delecluse</surname>
    <given-names>H.J.</given-names>
   </name>
   <name>
    <surname>Kenney</surname>
    <given-names>S.C.</given-names>
   </name>
  </person-group>
  <article-title>Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease</article-title>
  <source>Int. J. Cancer</source>
  <year>2007</year>
  <volume>121</volume>
  <fpage>1274</fpage>
  <lpage>1281</lpage>
  <pub-id pub-id-type="doi">10.1002/ijc.22839</pub-id>
  <?supplied-pmid 17520680?>
  <pub-id pub-id-type="pmid">17520680</pub-id>
 </element-citation>
</ref>
